Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?

dc.creatorFonseca A.
dc.creatorReis J.
dc.creatorSilva T.
dc.creatorMatos M.J.
dc.creatorBagetta D.
dc.creatorOrtuso F.
dc.creatorAlcaro S.
dc.creatorUriarte E.
dc.creatorBorges F.
dc.date.accessioned2020-09-02T22:17:54Z
dc.date.accessioned2022-11-08T20:23:36Z
dc.date.available2020-09-02T22:17:54Z
dc.date.available2022-11-08T20:23:36Z
dc.date.created2020-09-02T22:17:54Z
dc.date.issued2017
dc.identifier60, 16, 7206-7212
dc.identifier00222623
dc.identifierhttps://hdl.handle.net/20.500.12728/4497
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5144909
dc.languageen
dc.publisherAmerican Chemical Society
dc.titleCoumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
dc.typeArticle


Este ítem pertenece a la siguiente institución